In addition to RNA expression, levels of the cyclin D1 and PCNA proteins were not significantly altered, but combination treatment produced reductions in their protein expressions in HCT-116 cells (KRAS MT CRC). The gene discussed is KRAS; the disease is colorectal carcinoma.